Performance Evaluation and Validation of e-Lung in non-IPF fibrotic ILD - Vienna 2024

Breaking news in interstitial lung disease of known origin

Chair(s): Elisabetta Renzoni, Paolo Cameli

Session type: Oral presentation

Performance Evaluation and Validation of e-Lung in non-IPF fibrotic ILD

Michael Kreuter

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Interaction of High Air Pollution Exposure and MUC5B rs35705950 on Interstitial Lung Disease Risk in Rheumatoid Arthritis Patients

Lucile Sese

Replay

Poster

Abstract

Slides

Performance Evaluation and Validation of e-Lung in non-IPF fibrotic ILD

Michael Kreuter

Replay

Abstract

Slides

Predictive biomarkers of persistent interstitial changes after COVID19

Marta Hern?ndez Argudo

Replay

Poster

Abstract

Slides

Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Maria Otaola

Replay

Poster

Abstract

Slides

Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis

Ruxuan Chen

Replay

Poster

Abstract

Slides

Short telomere length is associated with disease progression in rheumatoid arthritis-associated interstitial lung disease

Kinan El Husseini

Replay

Abstract

Slides

Single-cell sequencing reveals enrichment of cross-presenting dendritic cells in fibrotic hypersensitivity pneumonitis

Ophir Freund

Poster

Abstract

Peripheral blood lymphocyte cell subsets in subjects with silicosis due to silica agglomerates

Gema Jimenez G?mez

Replay

Abstract

Slides

Lung Involvement in Early Rheumatoid Arthritis, Analysis of the FINDRA Cohort

Antoine Froidure

Replay

Poster

Abstract

Slides

Skin transcriptomics are associated with lung function impairment and distinct cell types in systemic sclerosis-related lung disease

Jana Zielonka

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}